14-day Premium Trial Subscription Try For FreeTry Free
The Joint Corp. (NASDAQ:JYNT ) Q1 2024 Earnings Conference Call May 2, 2024 5:00 PM ET Company Participants David Barnard – LHA Investor Relations Peter Holt – President and Chief Executive Office
The Joint Corp. (JYNT) came out with quarterly earnings of $0.06 per share, beating the Zacks Consensus Estimate of a loss of $0.03 per share. This compares to earnings of $0.15 per share a year ago.
SCOTTSDALE, Ariz., April 18, 2024 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT), the nation's largest provider of chiropractic care through The Joint Chiropractic ® network, announced it will re
The Joint Corp. (JYNT) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
The Joint Corp. (JYNT) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price incr
The Joint (JYNT) expects 2024 system-wide sales to be within $530-$545 million.
The Joint Corp. (JYNT) came out with quarterly earnings of $0.07 per share, beating the Zacks Consensus Estimate of $0.03 per share. This compares to earnings of $0.04 per share a year ago.
The Joint's (JYNT) fourth-quarter 2023 results are likely to reflect higher expenses and patient volumes.
SCOTTSDALE, Ariz., Feb. 22, 2024 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT), the nation's largest provider of chiropractic care through The Joint Chiropractic ® network, announced it will rep
The Joint Corp. (NASDAQ:JYNT ) Q3 2023 Earnings Call Transcript November 9, 2023 5:00 PM ET Company Participants Kirsten Chapman - Managing Director and Principal, HA Investor Relations Peter Holt - P
SCOTTSDALE, Ariz., Oct. 26, 2023 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT), the nation's largest provider of chiropractic care through The Joint Chiropractic ® network, announced it will rep

The Joint Corp.'s Q2 Was Not As Gloomy As It Seems

02:22pm, Wednesday, 18'th Oct 2023
JYNT's Q2 2023 results show growth in revenue, total clinic count, and system-wide sales. The company is still expanding, opening new clinics and selling franchise licenses. The management aims to imp
The Joint's (JYNT) new facility is positioned near the West Virginia University campus, at a high-traffic shopping center.
The Joint (JYNT) expects to open 100-120 franchised clinics in 2023 compared with 121 opened last year.
The Joint Corp. (JYNT) came out with a quarterly loss of $0.01 per share versus the Zacks Consensus Estimate of $0.03. This compares to earnings of $0.02 per share a year ago.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE